Connecting Ambitious Companies with the Right Investors

/ About Evvolve /

Evvolve & Partners combines its marketing background with our partners' extensive experience in the investment and banking sectors. We assist businesses in the capital markets to attract the attention of investors under any market conditions, raising the necessary funds to grow their enterprise value.

Our Engagments

Company

Aprinoia Therapeutics

Raised to date

$97M

Current Stage

Growth

Current Round

$15M

Company

Kanna Health Ltd

Raised to date

$12M

Current Stage

Pre-revenue

Current Round

$5M

Company

Phoreus Biotech

Raised to date

$97M

Current Stage

Growth

Current Round

$25M

Company

BlueThera Biologics Inc

Raised to date

$3.5M

Current Stage

Pre-revenue

Current Round

$30M

Company

Neovia Oncology

Raised to date

$15M

Current Stage

Pre-revenue

Current Round

$13M

Company

Stingray Therapeutics

Raised to date

$9M

Current Stage

Pre-revenue

Current Round

$20M

Company

CURX PHARMACEUTICALS, INC.

Raised to date

$7M

Current Stage

Pre-revenue

Current Round

$7M

Company

Altin Biosciences

Raised to date

Undisclosed

Current Stage

Pre-revenue

Current Round

$25M

Company

Caventure Drug Discovery, Inc

Raised to date

Undisclosed

Current Stage

Pre-revenue

Current Round

$25M

Company

AirMid Critical Care Products, Inc.

Raised to date

$2.4M

Current Stage

Pre-revenue

Current Round

$20M

Company

TLEHL

Raised to date

$200k

Current Stage

Pre-revenue

Current Round

$3M

Company

Tenboron Oy

Raised to date

$18.5M

Current Stage

Pre-revenue

Current Round

$8M

Company

VasoRx, Inc.

Raised to date

$12.5M

Current Stage

Pre-revenue

Current Round

$30M

Company

CADIS Engineering GmbH

Raised to date

$2.4M

Current Stage

Pre-revenue

Current Round

$5M

Ready To Evvolve Your Capital Raising Strategy?

Whether you're in the early stages of seeking capital or looking to expand your investor base, our team is ready to support your journey. Get in touch to discover how Evvolve & Partners can transform your capital raising efforts.

Let’s Talk